Alle Chancen

This analysis is generated by AI. It may be incomplete or inaccurate—please verify before acting.

79Score
r/algotrading
SaaS subscription
Build

Evidence-Based Factor Screener

Build a SaaS stock screener that ranks indicators by empirical strength, then lets users screen equities using value, quality, and momentum factors with transparent evidence scores. The product should emphasize historical robustness, transaction-cost awareness, and sector-specific behavior rather than hype around any single indicator.

Steigend +457%5 Kanäle30-Tage-Erwähnungstrend: latest 3, peak 4, 30-day series
Auf Reddit ansehen
Entdeckt 22. Juni 2026

Warum das wichtig ist

You want to select stocks with methods that have more than a good story behind them, but every indicator seems to have defenders, critics, and conflicting backtests. You can find academic papers, blog posts, and charting tools, yet none of them make it easy to answer a practical question: which signals still look credible after costs, across sectors, and over changing market conditions? If you are not already running your own research stack, you end up stitching together books, spreadsheets, and partial backtests. That creates uncertainty right where confidence matters most: before you commit capital.

  • · Entwickelt für Self-directed investors and serious retail traders who want academically grounded stock screens without building their own quant pipeline..
  • · Wahrscheinlichste Monetarisierung: SaaS subscription.

Der Schmerz · Narrativ

You want to select stocks with methods that have more than a good story behind them, but every indicator seems to have defenders, critics, and conflicting backtests. You can find academic papers, blog posts, and charting tools, yet none of them make it easy to answer a practical question: which signals still look credible after costs, across sectors, and over changing market conditions? If you are not already running your own research stack, you end up stitching together books, spreadsheets, and partial backtests. That creates uncertainty right where confidence matters most: before you commit capital.

Score-Details

Schmerzintensität9/10
Zahlungsbereitschaft6/10
Umsetzbarkeit6/10
Nachhaltigkeit7/10

Marktsignal

30-Tage-ErwähnungstrendSpitze: 4
Sparkline: latest 3, peak 4, 30-day series
Abgedeckte Kanäle
algotradingfront_pageproductivityChatGPTsaas

Markteinführung

Genauer Zielnutzer

Independent investors who already use stock screeners and want more evidence-driven factor selection without writing code.

Geschätzte Nutzeranzahl

~100K-300K active globally

Primärer Akquisekanal

SEO long-tail

Preisanker

$29/month

Erster Meilenstein

25 paying users from search traffic and finance-community outreach within 30 days

MVP-Umfang · 1–2 Wochen

Woche 1
  • Define 10 core factors with formulas and plain-English explanations
  • Connect one market data source and one fundamentals data source
  • Build a simple database schema for prices, fundamentals, and factor scores
  • Create a factor evidence page with research summary, caveats, and cost notes
  • Ship a basic stock screener UI with filters for value and cash-flow metrics
Woche 2
  • Add sector-relative comparisons for each factor
  • Build historical factor performance charts by decile
  • Add simple transaction-cost assumptions to reported results
  • Implement watchlists and saved screens
  • Launch a landing page with one free evidence report to collect emails
MVP-Funktionen: Prebuilt factor library with evidence ratings · Stock screening by value, cash flow, earnings yield, and quality metrics · Sector-relative factor views and historical robustness dashboards

Differenzierung

Bestehende Lösungen
Generic broker charting toolsCustom quant research stacksBooks and academic papers
Unser Ansatz
There is room for a user-friendly research and screening product that converts factor evidence, regime testing, and cost-aware validation into a practical decision tool for self-directed investors.

Warum dies scheitern könnte

Selbstwiderlegung — das wichtigste Vertrauenssignal

  1. 1The product may be perceived as another generic stock screener unless the evidence layer is clearly differentiated and trusted.
  2. 2Users may not convert if they can replicate core screens using free finance sites and public factor articles.
  3. 3Data licensing costs could compress margins before subscriber volume is high enough.

Evidenzzusammenfassung

Wie KI diese Erkenntnis synthetisiert hat — keine wörtlichen Zitate

The discussion repeatedly favors value and cash-flow-oriented metrics over common chart indicators when the goal is stock selection. Several participants point to long-horizon factor research, while others warn that technical indicators often degrade after costs or regime changes. There is also repeated interest in combining signals rather than trusting one metric alone, which supports a screener that surfaces evidence, caveats, and implementation context.

1 1 Beitrag analysiert5 5 KanäleAI · KI-synthetisiert · keine wörtliche Wiedergabe

Aktionsplan

Validiere diese Gelegenheit, bevor du Code schreibst

Empfohlener nächster Schritt

Bauen

Starke Nachfragesignale erkannt. Echter Schmerz und Zahlungsbereitschaft vorhanden — fang an, ein MVP zu bauen.

Landing Page Textpaket

Druckfertige Texte basierend auf echten Reddit-Kommentaren — direkt einfügen

Überschrift

Evidence-Based Factor Screener

Unterüberschrift

Build a SaaS stock screener that ranks indicators by empirical strength, then lets users screen equities using value, quality, and momentum factors with transparent evidence scores. The product should emphasize historical robustness, transaction-cost awareness, and sector-specific behavior rather than hype around any single indicator.

Für Wen

Für Self-directed investors and serious retail traders who want academically grounded stock screens without building their own quant pipeline.

Funktionsliste

✓ Prebuilt factor library with evidence ratings ✓ Stock screening by value, cash flow, earnings yield, and quality metrics ✓ Sector-relative factor views and historical robustness dashboards

Wo Validieren

Teile deine Landing Page in r/r/algotrading — genau dort wurden diese Schmerzpunkte entdeckt.

Registrieren, um die vollständige Tiefenanalyse freizuschalten

GTM, MVP-Umfang, Gründe für ein Scheitern, ActionPlan Copy Kit. Kostenlose Registrierung bietet 10 Detailansichten/Monat.

Report & PRDBUSINESS

Weitere Chancen im selben Thema

Automatisch von KI aus verwandten Diskussionen gruppiert

Häufig gestellte Fragen

Wer spürt diesen Schmerz?
Self-directed investors and serious retail traders who want academically grounded stock screens without building their own quant pipeline.
Ist das eine echte Chance?
Diese Chance erreicht 79/100 bei der zusammengesetzten Metrik von Pain Spotter (Schmerzintensität, Zahlungsbereitschaft, technische Machbarkeit und Nachhaltigkeit). Validieren Sie weiter, bevor Sie Entwicklungszeit investieren.
Wie sollte ich das validieren?
Führen Sie 5 Customer-Discovery-Gespräche mit der Zielgruppe, veröffentlichen Sie eine Landingpage mit Warteliste und prüfen Sie den verlinkten Quellbeitrag auf aktuelle Aktivitäten, bevor Sie mit der Entwicklung beginnen.